Anna Rajab
Dr. Anna Rajab (MD, DCH (IRE), MRCP(UK), PhD) is Consultant Clinical Geneticist and Director of National Genetic Centre at the Ministry of Health, Sultanate of Oman. She has experience in clinical Neonatal medicine, General Pediatrics, Clinical Genetics Service. In the research field, she worked on research in Clinical Genetics and Population Genetics of Omanis led to completion of Ph.D. Thesis “The Impact of Genetic diseases in Oman” in 1997, and research in collaboration with centres of Excellence in USA, UK, Germany and Netherlands carried out to improve care of Omani families affected by genetic diseases.
Dr. Anna got many international consultancy awards and honours: 1991 Advisor to the World Health Organization on research in Medical Genetics, Alexandria, Egypt. 2004 Advisor to World Health Organization (Genetics &Biotechnology) in Teheran, Iran. 2005 World Health Organization Award for research in Down Syndrome. 2008 Advisor to IPTC of European Commission on “Capacity Building for the transfer of genetic Knowledge into practice and Prevention”. 2010, 2011, 2012 Advisor to European Commission - Joint Research Centre and Institute for Health and Consumer Protection (IHCP) on Genetic Testing in Emerging economies. 2012 Advisor to the World Health Organization on research in Medical Genetics in Geneva, Switzerland. 2012 Shaikh Hamdan Award for Distinguished Personalities in Arab World. 2014 Honorary Consultant to BGI.
Abstract: “Development of Genetic Services in the Sultanate of Oman”
The Sultanate of Oman is a rapidly developing Muslim country with well organised Government funded healthcare services, including primary, secondary and tertiary levels of care and rapidly expanding medical genetic facilities. At the present time the Omani population is characterised by a rapid rate of growth, large family size, consanguineous marriages, and the presence of genetic isolates. The preservation of a tribal structure in the community coupled with traditional isolation has produced unique and favourable circumstances for building genealogical records and the study of genetic disease. Genetic services developed in the Sultanate of Oman in the past decade have become an important component of healthcare. The support in education, technology transfer, and research in collaboration with the C. Walch Laboratory at Harvard Institute of Neurology (USA), Weill Cornell College (USA), Institute of Human Genetics at Humboldt University (Berlin, Germany), Genetic Department of St-George’s Hospital Medical School (UK) and Leiden University (Netherlands) paved the way to success. The recently built National Genetic Centre in Muscat is expected to meet the needs of the Omani population in provision of genetic services and research, in a manner deferential to the cultural and religious traditions of the country.